Therapy for metastatic melanoma: the past, present, and future, BMC Medicine, vol.136, issue.8, p.23, 2012. ,
DOI : 10.1001/archsurg.136.8.950
Gaining momentum: New options and opportunities for the treatment of advanced melanoma, Cancer Treatment Reviews, vol.41, issue.8, pp.660-670, 2015. ,
DOI : 10.1016/j.ctrv.2015.05.012
The rapidly evolving therapies for advanced melanoma???Towards immunotherapy, molecular targeted therapy, and beyond, Critical Reviews in Oncology/Hematology, vol.99, pp.91-99, 2016. ,
DOI : 10.1016/j.critrevonc.2015.12.002
Advances in immunotherapy for melanoma, BMC Medicine, vol.33, issue.Suppl 3, 2016. ,
DOI : 10.1186/s12916-016-0571-0
URL : http://doi.org/10.1186/s12916-016-0571-0
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma, New England Journal of Medicine, vol.364, issue.26, pp.2517-2526, 2011. ,
DOI : 10.1056/NEJMoa1104621
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation, New England Journal of Medicine, vol.364, issue.26, pp.2507-2516, 2011. ,
DOI : 10.1056/NEJMoa1103782
Intra- and Inter-Tumoral Homogeneity of BRAFV600E Mutations in Melanoma Tumors, Journal of Investigative Dermatology, vol.135, issue.12, pp.3078-3085, 2015. ,
DOI : 10.1038/jid.2015.229
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma, The Oncologist, vol.18, issue.3, pp.314-322, 2013. ,
DOI : 10.1634/theoncologist.2012-0333
-(2-Diethylaminoethyl)benzamide Derivatives with High Melanoma Uptake:?? Structure???Affinity Relationships, Metabolic Fate, and Intracellular Localization, Journal of Medicinal Chemistry, vol.43, issue.21, pp.3913-3922, 2000. ,
DOI : 10.1021/jm991079p
-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma, Journal of Medicinal Chemistry, vol.51, issue.11, pp.3133-3144, 2008. ,
DOI : 10.1021/jm701424g
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide), J Nucl Med, vol.34, pp.1260-1266, 1993. ,
123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.11, pp.1478-1484, 2002. ,
DOI : 10.1007/s00259-002-0971-6
URL : http://doi.org/10.1007/s00259-002-0971-6
123I-BZA2 as a Melanin-Targeted Radiotracer for the Identification of Melanoma Metastases: Results and Perspectives of a Multicenter Phase III Clinical Trial, Journal of Nuclear Medicine, vol.55, issue.1, pp.15-22, 2014. ,
DOI : 10.2967/jnumed.113.123554
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.9, pp.1449-1461, 2012. ,
DOI : 10.1007/s00259-012-2168-y
Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma, Cancer Research, vol.70, issue.10, pp.4045-4053, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4414
Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution, Pigment Cell & Melanoma Research, vol.47, issue.5, pp.1-11, 2010. ,
DOI : 10.1111/j.1755-148X.2010.00716.x
I-labelled melanin-targeting heteroarylcarboxamide molecule, International Journal of Cancer, vol.27, issue.5, pp.1042-1053, 2013. ,
DOI : 10.1002/ijc.28103
URL : https://hal.archives-ouvertes.fr/in2p3-00926259
Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52, Journal of Nuclear Medicine, vol.55, issue.1, pp.9-14, 2014. ,
DOI : 10.2967/jnumed.112.112789
Synthesis, radioiodination and in??vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes, European Journal of Medicinal Chemistry, vol.63, pp.840-853, 2013. ,
DOI : 10.1016/j.ejmech.2012.11.047
Evaluation of Novel Fluorinated and Iodinated Radiotracers for PET Imaging and Targeted Radionuclide Therapy of Melanoma, Journal of Medicinal Chemistry, vol.56, issue.21, pp.8455-8467, 2013. ,
DOI : 10.1021/jm400877v
Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent, Journal of Chromatography B, vol.875, issue.2, pp.411-418, 2008. ,
DOI : 10.1016/j.jchromb.2008.09.021
Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand, Physics in Medicine and Biology, vol.59, issue.9, pp.2183-2198, 2014. ,
DOI : 10.1088/0031-9155/59/9/2183
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K, Cancer Cell, vol.18, issue.6, pp.683-695, 2010. ,
DOI : 10.1016/j.ccr.2010.11.023
Combination Therapies for Melanoma: A New Standard of Care?, American Journal of Clinical Dermatology, vol.33, issue.Suppl, pp.99-105, 2016. ,
DOI : 10.1007/s40257-016-0174-8
Targeted Radionuclide Therapy of Melanoma, Seminars in Nuclear Medicine, vol.46, issue.3, pp.250-259, 2016. ,
DOI : 10.1053/j.semnuclmed.2015.12.005
[ 123 I]ICF01012 melanoma imaging and [ 131 I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models, Eur J Dermatol, vol.25, pp.29-35, 2015. ,
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy, Oncotarget, vol.7, pp.12927-12936, 2016. ,
I labelled potential agent, International Journal of Cancer, vol.27, issue.3, pp.708-716, 2009. ,
DOI : 10.1002/ijc.24413
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: Comparison with 188Re radiolabel, Nuclear Medicine and Biology, vol.41, issue.3, pp.276-281, 2014. ,
DOI : 10.1016/j.nucmedbio.2013.12.015
Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes, Experimental Eye Research, vol.98, pp.23-27, 2012. ,
DOI : 10.1016/j.exer.2012.03.004
Ethnic and Mouse Strain Differences in Central Corneal Thickness and Association with Pigmentation Phenotype, PLoS ONE, vol.299, issue.8, 2011. ,
DOI : 10.1371/journal.pone.0022103.s001
URL : http://doi.org/10.1371/journal.pone.0022103